Cost and Costing in Pharmacoeconomics (Final)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/23

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

24 Terms

1
New cards

pharmacoeconomics

defines, measures, and compares the costs and consequences of pharmaceutical products and services

2
New cards

provides a way to a measure "value of money" for all stake holders

Why is a pharmacoeconomics important?

3
New cards

pharmaceutical care

patient-centered, outcomes-oriented pharmacy practice that requires the pharmacist to work in concert with the patient and the patient's other healthcare providers to promote health, to prevent disease, and to assess, monitor, initiate, and modify medication use to assure that

4
New cards

the medical model

-Mortality: a fatal outcome, death

-Physical and biological measures: BP, weight...

-Diagnostic test results: white blood cell count, serum cholesterol...

-Definable clinical events: stroke, heart attack...

5
New cards

Rationales for the medical model

-Useful in diagnosis and treatment

-Well-accepted by health care providers

6
New cards

Limitations of the medical model

May be multi-system (e.g. diabetes with complications), but only one-dimension

7
New cards

humanistic outcomes

Consequence of disease or treatment on patient’s functional status or quality of life: psycho-social and physical functioning, general health, well-being, and satisfaction

8
New cards

patient-reported outcome (PRO)

the measurement of any aspect of a patient's health status that comes directly from the patients

9
New cards

clinical-reported patient outcomes

-General impressions

Observation and test of functions

-Pharmacists as a source for outcomes

10
New cards

Patient-reported outcome (PRO)

-General perception of health

-Functional status

-Well-being

-symptoms

-Health-related quality of life

-Satisfaction with service

-Adherence

-Care preference

11
New cards

cost

resources (inputs) used in the production of a good or service

12
New cards

charge

the price or the amount that is charged to the payer

13
New cards

time horizon (time frame)

Time over which the pharmacoeconomic alternatives are evaluated

14
New cards

morbidity

condition resulting from the ailments associated with the disease

15
New cards

intangible cost

Costs associated with non-financial outcomes of disease and medical care (such as quality of life), which cannot be properly expressed in monetary terms

16
New cards

1.Identification of costs relevant to study

2.Measurement of resources used (Q): physical quantities

3.Valuation of resources (C = Price x Q)

What are the 3 tasks of costing?

17
New cards

costing

is the process of identifying the costs of a disease and/or its associated treatment, and of breaking them down, and relating them to the various aspects of the disease and treatment

18
New cards

macro-costing

use of relatively large groups or bundles of cost

19
New cards

micro-costing

each component of resource use

(e.g., lab tests, days of stay, drugs) is estimated

and a unit cost derived for each item

20
New cards

diagnosis-related groups (DRG)

gives the cost for each category of

case or hospital patient. Takes account of length of stay. Precision

depends on the level of detail in specifying the types of cases

21
New cards

Disease-specific per diem

gives the average daily cost

for treatments in each disease category. These may still

be quite broad

22
New cards

Average per diem

averages the per diem over all

categories of patient. Available in most health

care systems

23
New cards

micro-costing

What is the most precise costing?

24
New cards

average per diem

What is the least precise costing?